Topics of the NCT Trial Center´s newsletter in June 2017 are:
- REMOTUX, a phase II study with cetuximab in patients with metastatic colorectal cancer, successfully completed
- Sickle-cell disease registry of the GPOH
- Ethics and Laws are in Flux – News with reference to laws and regulations
Download (PDF-File): Newsletter June 2017 | English»
Download (PDF-File): Newsletter June 2017 | German»